Investment opportunity

We are looking for funding in order to move forward with our research and development. Read more below.

Investment opportunity

404 - Page was not found

Sivua eng/investors/ipo ei löytynyt tältä sivustolta

Search results

Medicortex and Dividend Announce a Pre-IPO Investment / Medicortex ja Dividend Julkistavat Ennakko-IPO Sijoituksen(News)
cortex as a part of a pre-IPO round Medicortex is currently conducting...

Medicortex Closes Successful Pre-IPO Funding Round(News)
ssfully completed the pre-IPO share issue. Medicortex is working with a certified advisor from Nordic CA. The IPO is planned for 2022...

Medicortex Finland Plc has published a press release regarding announcement of IPO(News)
initial public offering (IPO) and apply for listing on Nasdaq First North Growth Market Finland. The IPO is to take place 13.-22.6.2022...

Medicortex has published a company release: IPO and listing cancelled(News)
Initial Public Offering (IPO) and listing to the First North Growth Market Finland marketplace maintained by Nasdaq Helsinki Oy...

Tietoa meistä(Page)
austavan soveltumista lapsipotilaisiin, joiden aivot ovat vielä kehittymässä. Vertaisarvioitu artikkeli tutkimuksesta julkaistiin 2023. Kliini...

Drug development program(Page)
cal Entities), each with lipophilic properties for crossing the blood-brain-barrier (BBB), and each with at least two of the following neuro-p...

Jonne Virtanen lähti bioteknologiayhtiön mainoskasvoksi – ”Hiljaista epidemiaa esiintyy urheilujoukkueissa”(News)
sministeriöltä, ja patenttiportfolio on laaja...

Medicortex has published a company release: The Finnish Financial Supervisory Authority has approved a supplement to the Prospectus(News)
ink-text" target="_blank">IPO webpage.Read more: ...

A clinical trial for children started / Kliininen tutkimus lapsipotilaille alkanut(News)
Medicortex has started its third clinical trial at Satasairaala hospital in Pori, Finland. This trial will focus on children and adolescen...